TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
회사 코드TMDX
회사 이름Transmedics Group Inc
상장일May 02, 2019
설립일2018
CEODr. Waleed H. Hassanein, M.D.
직원 수728
유형Ordinary Share
회계 연도 종료May 02
주소200 Minuteman Road
도시ANDOVER
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호01810
전화19785520900
웹사이트https://www.transmedics.com/
회사 코드TMDX
상장일May 02, 2019
설립일2018
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음